about
Therapeutic use of microRNAs in lung cancerEvaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells.Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interactionCombination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerPatient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cellsMicroenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.The role of Steinernema feltiae body-surface lipids in host-parasite immunological interactions.DNA damage and repair activity after broccoli intake in young healthy smokers.Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology.Absorption of bioactive compounds from steamed broccoli and their effect on plasma glutathione S-transferase activity.Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing ImmunorecognitionExploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME TrialMetformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLCAntibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeCoated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer modelsCirculating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk
P50
Q28395179-F67D2724-0373-44C7-BB38-453E797B3590Q35060289-899C0707-6BD9-40CC-869B-36D30473B0FDQ35679203-52490B20-B90A-44E9-971B-3B51969E6EA6Q35744111-61A21DA4-FF5C-4BCA-AFD0-336987C1A3E1Q35884941-E93C2DFA-8343-4279-A033-50D0C039902DQ37644788-D905CEDE-E339-474F-964A-77E48473F8F7Q38739226-68874085-2F8B-4DCE-B4D0-0FBE99D743FEQ38823872-B0603F75-069E-4484-8DEE-1565005E3B50Q38856807-5E22703F-0C0C-4FEC-8984-FFBFBF005261Q39001187-B534BED0-D947-495C-8D91-A6EC2E52953BQ41158938-7FAC5739-751E-4F53-A177-47E5292AC043Q42043986-161F540B-112C-4A89-A7AF-EF45149BDDCBQ42936145-419349F3-E870-4BE9-A44C-B997A678BC2FQ44236009-2D7C68BB-98BF-4A03-8D6B-EACF41AA7CD3Q46020624-F6FF3186-C007-426A-8552-14F9F32550D4Q51095916-AF6D60DC-404C-4512-9B5E-172383A36E23Q55077886-5BF41867-1BB5-447D-BA00-0BD5B6A610FBQ59273678-054542E2-65E9-4F11-9EF7-D58F88D8537CQ90928136-7503154A-5AD4-49A0-8890-F23128D3544AQ91159351-082EBE42-4729-43F3-827B-617CB07D44CDQ91392607-FF64C2C3-BF8C-4EE5-B9A4-28707FD61BA5Q91830419-4F3D8710-32D1-4704-8444-147CFD9796D2Q93063421-10283C9E-C4B7-4F0D-8608-C28207B7C1BC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Moro
@ast
Massimo Moro
@en
Massimo Moro
@es
Massimo Moro
@nl
Massimo Moro
@sl
type
label
Massimo Moro
@ast
Massimo Moro
@en
Massimo Moro
@es
Massimo Moro
@nl
Massimo Moro
@sl
prefLabel
Massimo Moro
@ast
Massimo Moro
@en
Massimo Moro
@es
Massimo Moro
@nl
Massimo Moro
@sl
P1053
D-7120-2017
P106
P1153
35086525700
P21
P31
P3829
P496
0000-0003-2562-4007